{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:35Z","timestamp":1791639155460,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Domestic Animal Endocrinology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.domaniend.2004.06.010","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T14:54:10Z","timestamp":1090594450000},"page":"85-104","source":"Crossref","is-referenced-by-count":91,"title":["Primary hyperaldosteronism, a mediator of progressive renal disease in cats"],"prefix":"10.1016","volume":"28","author":[{"given":"S.","family":"Javadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Djajadiningrat-Laanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Kooistra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Voorhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"van Sluijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.G.A.M.","family":"van den Ingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rijnberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.domaniend.2004.06.010_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00041552-200005000-00006","article-title":"Pathology of progressive nephropathies","volume":"9","author":"Fogo","year":"2000","journal-title":"Curr Opin Neprhol Hypertens"},{"key":"10.1016\/j.domaniend.2004.06.010_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000060159","article-title":"Angiotensin II as a renal growth factor","volume":"135","author":"Wolf","year":"2001","journal-title":"Contrib Nephrol Karger"},{"key":"10.1016\/j.domaniend.2004.06.010_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000060153","article-title":"Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator","volume":"135","author":"Ruiz-Ortega","year":"2001","journal-title":"Contrib Nephrol Karger"},{"key":"10.1016\/j.domaniend.2004.06.010_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/014107680109400803","article-title":"Aldosterone as a determinant of cardiovascular and renal dysfunction","volume":"94","author":"Epstein","year":"2001","journal-title":"J Royal Soc Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041552-200101000-00016","article-title":"Aldosterone and renal disease","volume":"10","author":"Hostetter","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.domaniend.2004.06.010_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1523-1755.2003.00707.x","article-title":"Therapeutic benifit of spironolactone in experimental chronic cyclosporine A nephrotoxicity","volume":"63","author":"Feria","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.domaniend.2004.06.010_bib7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2460\/javma.2002.220.1799","article-title":"Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation","volume":"220","author":"Syme","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.domaniend.2004.06.010_bib8","first-page":"1604","article-title":"Hypokalemia in cats: 186 cases","volume":"194","author":"Dow","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.domaniend.2004.06.010_bib9","series-title":"Textbook of veterinary internal medicine","first-page":"1634","article-title":"Chronic renal failure","author":"Polzin","year":"2000"},{"key":"10.1016\/j.domaniend.2004.06.010_bib10","first-page":"1569","article-title":"Potassium depletion in cats: renal and dietary influences","volume":"191","author":"Dow","year":"1987","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.domaniend.2004.06.010_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2460\/ajvr.1997.58.05.535","article-title":"Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease","volume":"58","author":"Jensen","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.domaniend.2004.06.010_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1292\/jvms.60.805","article-title":"Non-invasive blood pressure measurements in cats: clinical significance of hypertension associated with chronic renal failure","volume":"60","author":"Mishina","year":"1998","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.domaniend.2004.06.010_bib13","first-page":"314","article-title":"Inter- and intraindividual variation in Doppler ultrasonic indirect blood pressure measurements in healthy cats","volume":"13","author":"Sparkes","year":"1999","journal-title":"J Vet Int Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/01652176.2001.9695074","article-title":"Hyperaldosteronism in a cat with metastasised adrenocortical tumour","volume":"23","author":"Rijnberk","year":"2001","journal-title":"Vet Q"},{"key":"10.1016\/j.domaniend.2004.06.010_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/vr.122.8.178","article-title":"Assessment of two tests for the diagnosis of canine hyperadrenocorticism","volume":"122","author":"Rijnberk","year":"1988","journal-title":"Vet Rec"},{"key":"10.1016\/j.domaniend.2004.06.010_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0739-7240(95)00046-H","article-title":"Urinary excretion of glucocorticoids in the diagnosis of hyperadrenocorticism in cats","volume":"12","author":"Goossens","year":"1995","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib17","series-title":"Clinical Biochemistry of Domestic Animals.","first-page":"553","article-title":"Adrenocortical Function.","author":"Rijnberk","year":"1997"},{"key":"10.1016\/j.domaniend.2004.06.010_bib18","series-title":"Clinical endocrinology of dogs and cats","first-page":"205","article-title":"Protocols for function tests","author":"Rijnberk","year":"1996"},{"key":"10.1016\/j.domaniend.2004.06.010_bib19","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1001\/archinte.1983.00350100064017","article-title":"Blood and extracellular fluid volume in patients with Bartter\u2019s syndrome","volume":"143","author":"Boer","year":"1983","journal-title":"Arch Int Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/clinchem\/31.1.149","article-title":"Confirmation of the optimal pH for measuring plasma renin activity in plasma","volume":"31","author":"Boer","year":"1985","journal-title":"Clin Chem"},{"key":"10.1016\/j.domaniend.2004.06.010_bib21","unstructured":"Javadi S, Slingerland LI, van de Beek MG, Boer P, Boer WH, Rijnberk A, Kooistra HS. Plasma renin activity and plasma concentrations of aldosterone, cortisol, ACTH, and \u03b1-MSH in healthy household cats. J Vet Int Med 2004; in press."},{"key":"10.1016\/j.domaniend.2004.06.010_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1090-0233(98)80039-7","article-title":"Plasma aldosterone concentration of cats","volume":"155","author":"Yu","year":"1998","journal-title":"Vet J"},{"key":"10.1016\/j.domaniend.2004.06.010_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1098-612X(99)90068-2","article-title":"Successful surgical treatment of a cat with primary aldosteronism","volume":"1","author":"MacKay","year":"1999","journal-title":"J Feline Med Surg"},{"key":"10.1016\/j.domaniend.2004.06.010_bib24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/ajh\/6.11.960","article-title":"Chronic pressure\u2013natriuresis relationship in dogs with inherited essential hypertension","volume":"6","author":"Papanek","year":"1993","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.domaniend.2004.06.010_bib25","unstructured":"National Research Council (NRC). Nutrient requirements of dogs. National Academy Press, Washington DC, 1986."},{"key":"10.1016\/j.domaniend.2004.06.010_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jn\/129.2.419","article-title":"Sodium requirement of adult cats for maintenance based on plasma aldosterone concentration","volume":"129","author":"Yu","year":"1999","journal-title":"J Nutr"},{"key":"10.1016\/j.domaniend.2004.06.010_bib27","unstructured":"Association of American Feed Control Official (AAFCO) nutrient allowances. Official Publication of the Association of American Feed control Officials Inc., Atlanta, GA, USA, 1994."},{"key":"10.1016\/j.domaniend.2004.06.010_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5326\/15473317-35-5-411","article-title":"Primary hyperaldosteronism in two cats","volume":"25","author":"Flood","year":"1999","journal-title":"J Am Anim Hosp Assoc"},{"key":"10.1016\/j.domaniend.2004.06.010_bib29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2460\/javma.2000.217.213","article-title":"Use of abdominal ultrasonography in the diagnosis of primary hyperaldosteronism in a cat","volume":"217","author":"Moore","year":"2000","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.domaniend.2004.06.010_bib30","first-page":"752","article-title":"K+ channels in adrenal zona glomerulosa cells I: characterization of distinct channel types","volume":"263","author":"Vassilev","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib31","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/endo-129-2-823","article-title":"Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa","volume":"129","author":"Kifor","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2004.06.010_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-2143(96)90165-1","article-title":"Role of epinephrine-induced hypokalemia in the regulation of renin and aldosterone in humans","volume":"127","author":"Kolloch","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib33","first-page":"661","article-title":"Primary aldosteronism","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib34","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Int Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.domaniend.2004.06.010_bib36","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib37","series-title":"Principles and practice of endocrinology and metabolism","first-page":"773","article-title":"Hyperaldosteronism","author":"Gill","year":"2001"},{"key":"10.1016\/j.domaniend.2004.06.010_bib38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0889-8529(05)70283-8","article-title":"Pheochromocytoma and primary aldosteronism: diagnostic approaches","volume":"26","author":"Young","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.domaniend.2004.06.010_bib39","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.domaniend.2004.06.010_bib40","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","article-title":"Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.","volume":"89","author":"Pacoe","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.domaniend.2004.06.010_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI111941","article-title":"Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension","volume":"76","author":"Griffing","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.domaniend.2004.06.010_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0029-1210972","article-title":"Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism","volume":"95","author":"Miyamori","year":"1990","journal-title":"Exp Clin Endocrinol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00004872-199917030-00014","article-title":"The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women","volume":"17","author":"Harvey","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.domaniend.2004.06.010_bib45","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/en.141.12.4629","article-title":"Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats","volume":"141","author":"Roesch","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.domaniend.2004.06.010_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0303-7207(02)00285-X","article-title":"The role of luteinizing hormone in the pathogenesis of hyperadenocorticism in neutered ferrets","volume":"197","author":"Schoemaker","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib47","first-page":"382","article-title":"Lithium clearance in mineralocorticoid escape in humans","volume":"252","author":"Boer","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/acta.0.1030365","article-title":"Primary hyperparathyroidism associated with primary hyperaldosteronism","volume":"103","author":"Ferris","year":"1983","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(85)90328-6","article-title":"Calcium metabolim and parathyroid function in primary aldosteronism","volume":"78","author":"Resnick","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib50","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/00004872-199311000-00011","article-title":"Parathyroid hypertensive factor-like activity in human essential hypertension: relationship to plasma renin activity and dietary salt sensitivity","volume":"11","author":"Resnick","year":"1993","journal-title":"J Hypertens"},{"key":"10.1016\/j.domaniend.2004.06.010_bib51","first-page":"11","article-title":"Clinical aspects of parathyroid hypertensive factor","volume":"12","author":"Lewanczuk","year":"1994","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.domaniend.2004.06.010_bib52","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/archsurg.1970.01340220174029","article-title":"The kidney in endocrine hypertension. Cushing\u2019s syndrome, pheochromocytoma, and aldosteronism","volume":"100","author":"O\u2019Neal","year":"1970","journal-title":"Arch Surg"},{"key":"10.1016\/j.domaniend.2004.06.010_bib53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0022-5347(17)58376-7","article-title":"Renal changes in primary aldosteronism","volume":"117","author":"Danforth","year":"1977","journal-title":"J Urol"},{"key":"10.1016\/j.domaniend.2004.06.010_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0090-4295(96)00166-5","article-title":"Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma","volume":"48","author":"Grady","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.domaniend.2004.06.010_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0002-9343(73)90128-9","article-title":"Vasoconstriction volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles","volume":"55","author":"Laragh","year":"1973","journal-title":"Am J Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(75)90527-6","article-title":"The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension","volume":"58","author":"Laragh","year":"1975","journal-title":"Am J Med"},{"key":"10.1016\/j.domaniend.2004.06.010_bib57","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.85.9.3266","article-title":"Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage","volume":"85","author":"Oelkers","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.domaniend.2004.06.010_bib58","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(01)80115-3","article-title":"Aldosterone as a mediator of progressive renal disease: pathogenic and clinical implications","volume":"37","author":"Epstein","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["Domestic Animal Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724004000931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724004000931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:09:19Z","timestamp":1734484159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0739724004000931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0739724004000931"],"URL":"https:\/\/doi.org\/10.1016\/j.domaniend.2004.06.010","relation":{},"ISSN":["0739-7240"],"issn-type":[{"value":"0739-7240","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}